VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
RGNX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
RGNXREGENXBIO Inc.
$15.02$776M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksRGNXQuarterly Financials

REGENXBIO Inc. (RGNX) Quarterly Financials

120+ quarters historyFree accessUpdated daily

REGENXBIO Inc. (RGNX) quarterly income statement — complete revenue, gross profit & net income history

RGNX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue6.39M30.34M29.73M21.36M89.01M21.21M24.2M22.3M15.62M22.21M28.91M19.98M19.14M31.34M26.51M32.65M22.22M398.65M30.77M22.04M
Revenue Growth %-92.82%43%22.88%-4.2%469.79%-4.5%-16.31%11.6%-18.37%-29.13%9.06%-38.81%-13.86%-92.14%-13.85%48.17%17.66%1758.96%-68.89%33.01%
Cost of Goods Sold11.07M5.93M61.83M9.11M3.44M6.32M12.39M14.63M8.46M15.57M12.39M9.47M4.11M12.78M13.09M12.95M15.72M23.06M14.11M9.82M
COGS % of Revenue173.22%19.54%207.94%42.67%3.86%29.78%51.19%65.62%54.17%70.11%42.84%47.43%21.49%40.78%49.39%39.67%70.74%5.78%45.84%44.56%
Gross Profit-4.68M24.41M-32.09M12.24M85.58M14.9M11.81M7.67M7.16M6.64M16.53M10.5M15.03M18.56M13.42M19.7M6.5M375.6M16.67M12.22M
Gross Margin %-73.22%80.46%-107.94%57.33%96.14%70.22%48.81%34.38%45.83%29.89%57.16%52.57%78.51%59.22%50.61%60.33%29.26%94.22%54.16%55.44%
Gross Profit Growth %-105.47%63.86%-371.74%59.75%1095.36%124.34%-28.54%-27.01%-52.36%-64.23%23.16%-46.68%131.13%-95.06%-19.5%61.25%-53.67%3257.14%-79.56%2.81%
Operating Expenses78.68M82.05M20.32M75.52M73.45M66.26M73.89M63.7M68.92M70.54M81.49M83.61M81.18M76.33M84.46M82.23M78.03M62M74.02M64.44M
OpEx % of Revenue1230.74%270.45%68.33%353.59%82.52%312.36%305.36%285.72%441.18%317.58%281.82%418.53%424.2%243.53%318.58%251.86%351.19%15.55%240.52%292.45%
Selling, General & Admin21.31M22.38M20.25M19.88M20.35M20.05M19.42M18.86M18.29M19.08M23.08M23.7M22.63M21.21M20.92M20.83M22.32M22.04M21.03M18.43M
SG&A % of Revenue333.27%73.77%68.12%93.09%22.86%94.52%80.27%84.57%117.08%85.89%79.83%118.63%118.27%67.67%78.91%63.81%100.45%5.53%68.34%83.62%
Research & Development57.34M59.61M56.1M55.59M53.09M50.38M54.43M44.82M50.66M51.35M58.18M59.89M58.52M62.51M63.31M61.01M55.63M47.98M47.85M45.88M
R&D % of Revenue896.9%196.5%188.68%260.29%59.64%237.48%224.94%201.02%324.31%231.15%201.23%299.77%305.76%199.41%238.81%186.86%250.37%12.04%155.51%208.22%
Other Operating Expenses36K54K-1000K45K15K-1000K37K29K-34K118K220K26K33K-1000K229K391K83K-1000K1000K135K
Operating Income-83.36M-57.64M-52.41M-63.28M12.13M-51.37M-62.08M-56.04M-61.76M-63.9M-64.96M-73.11M-66.16M-57.77M-71.05M-62.53M-71.53M313.6M-57.35M-52.23M
Operating Margin %-1303.96%-189.99%-176.27%-296.26%13.62%-242.14%-256.55%-251.34%-395.35%-287.68%-224.67%-365.96%-345.68%-184.31%-267.97%-191.53%-321.93%78.66%-186.36%-237.01%
Operating Income Growth %-787.41%-12.2%15.57%-12.92%119.64%19.62%4.44%23.35%6.64%-10.61%8.57%-16.91%7.51%-118.42%-23.88%-19.74%-62.41%684.51%-511.07%-24.84%
EBITDA-83.36M-53.77M-48.52M-59.37M16.08M-47.34M-58.12M-51.99M-57.58M-59.57M-60.59M-68.67M-61.98M-53.65M-67.5M-59.89M-68.94M316.2M-54.52M-50.02M
EBITDA Margin %-1303.96%-177.23%-163.2%-277.98%18.07%-223.18%-240.18%-233.17%-368.6%-268.17%-209.55%-343.76%-323.85%-171.14%-254.59%-183.44%-310.27%79.32%-177.17%-227.03%
EBITDA Growth %-618.36%-13.56%16.5%-14.21%127.93%20.52%4.08%24.3%7.09%-11.04%10.23%-14.67%10.09%-116.97%-23.8%-19.72%-63.69%713.44%-438.07%-26%
D&A (Non-Cash Add-back)03.87M3.89M3.9M3.96M4.02M3.96M4.05M4.18M4.33M4.37M4.43M4.18M4.13M3.55M2.64M2.59M2.61M2.83M2.2M
EBIT-83.36M-54.87M-48.77M-59.88M14.65M-41.77M-58.78M-52.54M-61.36M-61.68M-60.24M-70.94M-63.92M-55.67M-69.53M-61.32M-70.63M313.93M-51.7M-51.27M
Net Interest Income8.71M-12.26M-13.17M-7.59M-8.54M-9.33M-795K-420K-1.94M1M-1.57M-1.08M-2.69M-4.23M-5.94M-6.71M-6.04M-6.48M-6.59M-5.81M
Interest Income018K03.4M083K25K29K37K2.37M56K40K70K77K18K153K94K19K117K554K
Interest Expense-8.71M12.28M13.17M10.99M8.57M9.42M820K449K1.97M1.36M1.62M1.12M2.75M4.31M5.95M6.86M6.13M6.5M6.71M6.37M
Other Income/Expense-6.69M-9.51M-9.53M-7.59M-6.04M182K2.48M3.05M-1.57M862K3.09M1.05M-519K-2.21M-4.44M-5.65M-5.24M-6.17M-1.06M-5.41M
Pretax Income-90.05M-67.15M-61.94M-70.87M6.08M-51.19M-59.6M-52.99M-63.33M-63.04M-61.87M-72.06M-66.68M-59.98M-75.48M-68.18M-76.76M307.43M-58.41M-57.64M
Pretax Margin %-1408.59%-221.34%-208.32%-331.81%6.83%-241.28%-246.3%-237.67%-405.39%-283.8%-213.97%-360.72%-348.4%-191.35%-284.72%-208.82%-345.5%77.12%-189.79%-261.58%
Income Tax000000000-152K000-43K00-41K13.4M00
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0.24%0%0%0%0.07%0%0%0.05%4.36%0%0%
Net Income-90.05M-67.15M-61.94M-70.87M6.08M-51.19M-59.6M-52.99M-63.33M-62.89M-61.87M-72.06M-66.68M-59.94M-75.48M-68.18M-76.72M294.02M-58.41M-57.64M
Net Margin %-1408.59%-221.34%-208.32%-331.81%6.83%-241.28%-246.3%-237.67%-405.39%-283.12%-213.97%-360.72%-348.4%-191.21%-284.72%-208.82%-345.32%73.75%-189.79%-261.58%
Net Income Growth %-1580.37%-31.19%-3.93%-33.75%109.61%18.61%3.67%26.47%5.02%-4.93%18.04%-5.69%13.1%-120.38%-29.24%-18.29%-53.02%735.85%-764.37%-70.72%
Net Income (Continuing)-90.05M-67.15M-61.94M-70.87M6.08M-51.19M-59.6M-52.99M-63.33M-62.89M-61.87M-72.06M-66.68M-59.94M-75.48M-68.18M-76.72M294.02M-58.41M-57.64M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-1.72-1.30-1.20-1.380.12-1.01-1.17-1.05-1.38-1.43-1.41-1.66-1.61-1.38-1.85-1.58-1.796.67-1.37-1.36
EPS Growth %-1533.33%-28.71%-2.56%-31.43%108.7%29.37%17.02%36.75%14.29%-3.62%23.78%-5.06%10.06%-120.69%-35.04%-16.18%-49.17%637.9%-695.65%-49.45%
EPS (Basic)-1.72-1.30-1.20-1.380.12-1.01-1.17-1.05-1.38-1.43-1.41-1.66-1.61-1.38-1.85-1.58-1.796.87-1.37-1.36
Diluted Shares Outstanding52.43M51.75M51.69M51.48M51.43M50.87M50.8M50.6M45.73M44M43.95M43.53M43.45M43.3M43.25M43.11M42.94M44.08M42.63M42.51M
Basic Shares Outstanding52.43M51.75M51.69M51.48M51.36M50.87M50.8M50.6M45.73M44M43.95M43.53M43.45M43.3M43.25M43.11M42.94M42.77M42.63M42.51M
Dividend Payout Ratio--------------------